Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 10 | Biological Research

Fig. 10

From: Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models

Fig. 10

(A) Triple immunostaining at 40x magnification for Iba1, TH and GFAP, nuclei were counterstained with DAPI. On the left, it is possible to appreciate 20x magnification, while on the right higher magnification for TH, Iba1 and GFAP staining and merge figures were shown. (B) Histograms for GFAP and Iba1 show the fluorescence intensity, as % of controls. (C) Western blotting and relative densitometric analysis for mBDNF, pCREB and pAKT in the striatum and substantia nigra *** p < 0.0005; ** p < 0.005; * p < 0.05 vs. CTR; +++ p < 0.0005, ++ p < 0.005 vs. 6-OHDA.

Back to article page

Biological Research

ISSN: 0717-6287

Contact us